LEKLI sh.p.k has completed the first stage of establishing the line of human drug production for producing Oral Solid Dosage (OSD) and Oral Liquid Dosage pharmaceutical forms for internal use.

A modern contemporary facility was established through a considerable financial investment and two years of intensive work, alongside with consultations and strategic partnership with a German pharmaceutical company.

The two-story building of 2000 m² is located in the “Tirana Industrial Park” complex, on the TR-DR motorway, Km 7, Kashar Overpass, only 11 km from Tirana.

The facility was designed and constructed to qualitatively and quantitatively enhance and develop our production, in compliance with the requirements of Good Manufacturing Practices (cGMP) regarding solid and liquid dosage pharmaceutical forms for internal use.

The production of medicines will include orphan, virological, oncological and respiratory disease drugs.

ABOUT LEKLI SH.P.K

LEKLI sh.p.k is a pharmaceutical company focused on market research and manufacture of medical products for human use.Our experience in pharmaceuticals began in 1986 and resulted in the establishment of LEKLI sh.p.k in 1991 by Dr. Luan Lekli. During these years, LEKLI sh.p.k managed to grow from a well- established Pharma company to a company with cross border presence.
In the following years, we specialized in the field of rare diseases, leading the market and making sure that every single patient is able to live a better life. In 2015, LEKLI sh.p.k established a production facility, manufacturing generic drugs, Phytotherapeutics and orphan drugs. To cover all the needs of the Albanian market, we produce prescription, non-prescription, extemporaneous and stock pharmaceutical preparations.
Our experience spans more than 25 years in the Balkan market, during which we have established our presence through our operations in Albania and in Kosovo. Today we have a strong brand equity and awareness. Together with our highly motivated, experienced and empowered management team we lead the market in special indications areas.
For more information: www.leklipharma.com/al/